[{"Assets_0_Q1_USD":"26119200000.0","CIK":"875045","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"8.1","EarningsPerShareDiluted_1_Q1_USD":"8.08","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"32775642095.0","MinorityInterest_0_Q1_USD":"-10000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"1467300000.0","NetIncomeLoss_1_Q1_USD":"1399100000.0","OfficialName":"Biogen Inc. Common Stock","ProfitLoss_1_Q1_USD":"1392600000.0","RevenuesConverted_1_Q1_USD":"3534300000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"12536900000.0","StockholdersEquity_0_Q1_USD":"12546900000.0","Ticker":"BIIB","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"173100000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"172800000.0","filed":"20200423","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"BIOGEN INC.","period":"20200331","qtrs":"0","uom":"USD"}]